Evidence map›Paper›PMID 36302059›Full record

ArticlePloS one2022

Collagen cross-links scale with passive stiffness in dystrophic mouse muscles, but are not altered with administration of a lysyl oxidase inhibitor.

Sarah E Brashear, Ross P Wohlgemuth, Lin-Ya Hu, Elias H Jbeily, Blaine A Christiansen, Lucas R Smith

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Muscle Quality Responses of Pearl Gentian Grouper (Foods (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Thrown for a loop: fibro-adipogenic progenitors in skeletal muscle fibrosis.American journal of physiology. Cell physiology · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sarah E BrashearDepartment of Neurobiology, Physiology, and Behavior, University of California Davis, Davis, California, United States of America.ORCID 0000-0003-4601-3520
Ross P WohlgemuthDepartment of Neurobiology, Physiology, and Behavior, University of California Davis, Davis, California, United States of America.ORCID 0000-0002-1841-2148
Lin-Ya HuDepartment of Neurobiology, Physiology, and Behavior, University of California Davis, Davis, California, United States of America.
Elias H JbeilyDepartment of Orthopaedic Surgery, University of California Davis, Sacramento, California, United States of America.
Blaine A ChristiansenDepartment of Orthopaedic Surgery, University of California Davis, Sacramento, California, United States of America.
Lucas R SmithDepartment of Neurobiology, Physiology, and Behavior, University of California Davis, Davis, California, United States of America.ORCID 0000-0002-7610-4231
University of California, Davis · US

Funding

Interdependency of fibroadipogenic progenitors and extracellular matrix that drive skeletal muscle fibrosisR01AR079545 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LUCAS R SMITH · 2022 to 2026
$2.5M
The role of collagen organization in determination of fibrotic muscle function and regenerationR00AR067867 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SMITH, LUCAS R · 2018 to 2020
$741k
NIAMS NIH HHS R00 AR067867NIAMS NIH HHS R01 AR079545
6 · The paper itself

Abstract

In Duchenne muscular dystrophy (DMD), a lack of functional dystrophin leads to myofiber instability and progressive muscle damage that results in fibrosis. While fibrosis is primarily characterized by an accumulation of extracellular matrix (ECM) components, there are changes in ECM architecture during fibrosis that relate more closely to functional muscle stiffness. One of these architectural changes in dystrophic muscle is collagen cross-linking, which has been shown to increase the passive muscle stiffness in models of fibrosis including the mdx mouse, a model of DMD. We tested whether the intraperitoneal injections of beta-aminopropionitrile (BAPN), an inhibitor of the cross-linking enzyme lysyl oxidase, would reduce collagen cross-linking and passive stiffness in young and adult mdx mice compared to saline-injected controls. We found no significant differences between BAPN treated and saline treated mice in collagen cross-linking and stiffness parameters. However, we observed that while collagen cross-linking and passive stiffness scaled positively in dystrophic muscles, collagen fiber alignment scaled with passive stiffness distinctly between muscles. We also observed that the dystrophic diaphragm showed the most dramatic fibrosis in terms of collagen content, cross-linking, and stiffness. Overall, we show that while BAPN was not effective at reducing collagen cross-linking, the positive association between collagen cross-linking and stiffness in dystrophic muscles still show cross-linking as a viable target for reducing passive muscle stiffness in DMD or other fibrotic muscle conditions.

Indexed as

Muscular Dystrophy, DuchenneProtein-Lysine 6-OxidaseAminopropionitrileAnimalsCollagenDisease Models, AnimalFibrosisMiceMice, Inbred mdxMuscle, SkeletalAminopropionitrileCollagenProtein-Lysine 6-Oxidase

Identifiers

PMID36302059
PMCPMC9612445
OpenAlexW4307412559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.